October 29, 2013

Generic drug maker Amneal Pharmaceuticals is seeking Food and Drug Administration approval for a gout drug, prompting a lawsuit from the maker of the branded version, according to published reports.

October 25, 2013

In recognition of National Prescription Drug Take Back Day being held Oct. 26, CVS/pharmacy has launched the CVS/pharmacy Medication Disposal for Safer Communities Program.

October 24, 2013

With the expansion of Medicaid services in the Patient Protection and Affordable Care Act on the horizon, the National Association of Chain Drug Stores and National Community Pharmacists Association sent a letter to CMS urging the agency to take into consideration the true cost of dispensing prescription medications to Medicaid patients.

October 22, 2013

A top executive of generic drug maker Hospira spoke in favor of giving biosimilar drugs the same generic names as the branded biologics they're based on.

October 22, 2013

The Food and Drug Administration has approved a new generic drug for treating bacterial and protozoan infections, according to the agency.

October 22, 2013

The Food and Drug Administration, in a complaint filed by the U.S. Department of Justice, on Monday sought a permanent injunction against the dietary supplement manufacturer James G. Cole; its president, James Cole; and its general manager, Julie Graves, following the company’s repeated distribution of unapproved drugs and adulterated dietary supplements in violation of the Federal Food, Drug and Cosmetic Act.

October 22, 2013

Keeping counterfeit and diverted drugs out of the U.S. drug supply chain will require closing vulnerable regulatory gaps that risk letting them in, according to a new report by the National Association of Boards of Pharmacy.

October 22, 2013

The state Senate of Pennsylvania will vote on a bill to curb misuse of prescription drugs, according to published reports.

October 21, 2013

The Food and Drug Administration is offering more than $14 million in grants for the development of products for patients with rare diseases, the agency said.

October 17, 2013

As knock-off versions of biotech drugs get closer to reality in the United States, one issue that has emerged has centered on what to call them.

October 17, 2013

Prasco Labs will distribute an authorized generic for reducing serum phosphate in patients with end-stage renal disease under a contract with Shire, Prasco said Thursday.

October 16, 2013

Medicare beneficiaries' use of medications — both effective and risky — varies widely across different regions of the United States, according to a new report.

October 15, 2013

CVS/pharmacy is offering its senior patients a new way to compare Medicare Part D prescription drug plans during the annual enrollment period from Oct. 15 to Dec. 7, the pharmacy retailer has announced.

October 15, 2013

The National Community Pharmacists Association Tuesday morning spelled out its public policy agenda — including the push to get H.R. 3204, The Drug Quality and Security Act, enacted — and expressed optimism for the future of community pharmacy during a media briefing held in conjunction with NCPA’s 115th Annual Convention and Trade Exposition in Orlando, Fla.

October 14, 2013

The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

October 14, 2013

More than three-quarters of Medicare beneficiaries don't compare drug prices when shopping for their health plans, according to a new study.

October 14, 2013

With this year’s Medicare Annual Election Period overlapping with the unrelated open enrollment for the new federal and state insurance marketplaces, there’s a growing need to help Medicare beneficiaries understand their healthcare coverage options when Medicare open enrollment begins on Oct. 15, Walgreens noted Monday.

October 11, 2013

Auxilium Pharmaceuticals will have exclusive rights to market a drug for erectile dysfunction in the United States and Canada, under a new licensing agreement with the drug's manufacturer.

October 11, 2013

A new law in Maine will allow the importation of drugs from abroad through mail-order from some pharmacies, formalizing a practice that has existed in many parts of the country for several years, and marking the first time a state government has, by law, gone against Food and Drug Administration regulations that bar importation of drugs.

Bloomberg columnist Megan McArdle said Maine was "going rogue" on drug importation, and that pretty much sums it up. The state, which has long had a close relationship with Canada — its governor, Paul LePage, is of French-Canadian descent and spoke Quebecois French as his first language — is openly defying federal law. And because federal law ultimately trumps state law, it's likely the federal government will crack down at some point.

October 10, 2013

One of the Food and Drug Administration's top regulators is not retiring, contrary to rumors reported in news media Thursday.

October 10, 2013

For the Food and Drug Administration’s Office of Generic Drugs, one of the biggest stumbling blocks has been its significant backlog of generic drug approval applications. But it’s steadily making progress in addressing the problem.

October 10, 2013

A coalition of organizations that includes major retail pharmacy and drug manufacturing groups is warning consumers against purchasing drug from foreign, online outlets.

October 10, 2013

While the boom in generic drugs now looks set to wane, another segment of the pharmaceutical industry is rapidly rising and presenting new growth opportunities for pharmacy retailers: specialty drugs.

October 8, 2013

Consumers in the United States are more likely than those in three other countries to say they prefer to receive generic drugs over branded drugs, according to a new study.